abstract |
The present invention relates to novel peptidomimetic compounds capable of binding to and / or neutralizing influenza viruses, particularly phylogenetic group 1 influenza A viruses, and pharmaceutical compositions comprising such compounds. The invention also relates to the use of peptidomimetic compounds in the diagnosis, prevention and / or treatment of influenza virus infection. |